How much debt does Interpace Biosciences have?

According to Interpace Biosciences's latest annual financial reports, the company's debt profile is as follows:

Total Debt and Liabilities

Interpace Biosciences's total debt stands at $11.19M. This is broken down into:

• Long-term debt: $4.24M
• Short-term debt: $5.48M

The company's net debt, which accounts for cash and cash equivalents, is $7.69M. In terms of overall financial obligations, Interpace Biosciences's total liabilities amount to $28.16M.

Debt Ratios and Metrics

To better understand Interpace Biosciences's debt position, we can look at several key ratios:

• Debt to Equity Ratio: -0.64 - this indicates the proportion of equity and debt the company uses to finance its assets.
• Debt Ratio: 74.65% - this shows the proportion of a company's assets that are financed through debt.
• Interest Coverage Ratio: 2.79 - this measures how easily a company can pay interest on its outstanding debt.
• Long-term Debt to Capitalization: -38.95% - this shows the proportion of long-term debt in the company's capital structure.
• Total Debt to Capitalization: -179.47% - this indicates the total debt in the company's capital structure.

These metrics provide insight into Interpace Biosciences's financial leverage and its ability to meet financial obligations. For a comprehensive understanding of the company's financial health, it's important to consider these debt metrics alongside other financial indicators and industry benchmarks.